BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38367219)

  • 1. Discovery of a Potent Nicotinamide Phosphoribosyltransferase Activator for Improving Aging-associated Dysfunctions.
    Yang S; Sun D; Wu Y; Chen S; Guo Y; Li J; Dong G; Sheng C
    J Med Chem; 2024 Mar; 67(5):4120-4130. PubMed ID: 38367219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of DS68702229 as a Potent, Orally Available NAMPT (Nicotinamide Phosphoribosyltransferase) Activator.
    Akiu M; Tsuji T; Iida K; Sogawa Y; Terayama K; Yokoyama M; Tanaka J; Asano D; Honda T; Sakurai K; Pinkerton AB; Nakamura T
    Chem Pharm Bull (Tokyo); 2021; 69(11):1110-1122. PubMed ID: 34719594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotinamide Phosphoribosyltransferase as a Key Molecule of the Aging/Senescence Process.
    Khaidizar FD; Bessho Y; Nakahata Y
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33918226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of a urea-containing series of nicotinamide phosphoribosyltransferase (NAMPT) activators.
    Pinkerton AB; Sessions EH; Hershberger P; Maloney PR; Peddibhotla S; Hopf M; Sergienko E; Ma CT; Smith LH; Jackson MR; Tanaka J; Tsuji T; Akiu M; Cohen SE; Nakamura T; Gardell SJ
    Bioorg Med Chem Lett; 2021 Jun; 41():128007. PubMed ID: 33798699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of small-molecule activators of nicotinamide phosphoribosyltransferase (NAMPT) and their preclinical neuroprotective activity.
    Yao H; Liu M; Wang L; Zu Y; Wu C; Li C; Zhang R; Lu H; Li F; Xi S; Chen S; Gu X; Liu T; Cai J; Wang S; Yang M; Xing GG; Xiong W; Hua L; Tang Y; Wang G
    Cell Res; 2022 Jun; 32(6):570-584. PubMed ID: 35459935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme of the nicotinamide adenine dinucleotide (NAD) salvage pathway, to target glioma heterogeneity through mitochondrial oxidative stress.
    Sharma P; Xu J; Williams K; Easley M; Elder JB; Lonser R; Lang FF; Lapalombella R; Sampath D; Puduvalli VK
    Neuro Oncol; 2022 Feb; 24(2):229-244. PubMed ID: 34260721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of NAMPT in aging retinal pigment epithelium reduces NAD
    Jadeja RN; Powell FL; Jones MA; Fuller J; Joseph E; Thounaojam MC; Bartoli M; Martin PM
    Aging (Albany NY); 2018 Jun; 10(6):1306-1323. PubMed ID: 29905535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of Allosteric Modulation of Nicotinamide Phosphoribosyltransferase to Elevate Cellular NAD
    Ratia KM; Shen Z; Gordon-Blake J; Lee H; Laham MS; Krider IS; Christie N; Ackerman-Berrier M; Penton C; Knowles NG; Musku SR; Fu J; Velma GR; Xiong R; Thatcher GRJ
    Biochemistry; 2023 Feb; 62(4):923-933. PubMed ID: 36746631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotinamide Phosphoribosyltransferase (Nampt)/Nicotinamide Adenine Dinucleotide (NAD) Axis Suppresses Atrial Fibrillation by Modulating the Calcium Handling Pathway.
    Feng D; Xu D; Murakoshi N; Tajiri K; Qin R; Yonebayashi S; Okabe Y; Li S; Yuan Z; Aonuma K; Ieda M
    Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32629939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NAMPT-Mediated NAD Biosynthesis as the Internal Timing Mechanism: In NAD+ World, Time Is Running in Its Own Way.
    Poljsak B
    Rejuvenation Res; 2018 Jun; 21(3):210-224. PubMed ID: 28756747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, Optimization, and Structure-Activity Relationships of Nicotinamide Phosphoribosyltransferase (NAMPT) Positive Allosteric Modulators (N-PAMs).
    Shen Z; Ratia K; Krider I; Ackerman-Berrier M; Penton C; Musku SR; Gordon-Blake JM; Laham MS; Christie N; Ma N; Fu J; Xiong R; Courey JM; Velma GR; Thatcher GRJ
    J Med Chem; 2023 Dec; 66(24):16704-16727. PubMed ID: 38096366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel carbon skeletons activate human NicotinAMide Phosphoribosyl Transferase (NAMPT) enzyme in biochemical assay.
    Almeida KH; Avalos-Irving L; Berardinelli S; Chauvin K; Yanez S
    PLoS One; 2023; 18(3):e0283428. PubMed ID: 36996070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of 1-[2-(1-methyl-1H-pyrazol-5-yl)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]-3-(pyridin-4-ylmethyl)urea as a potent NAMPT (nicotinamide phosphoribosyltransferase) activator with attenuated CYP inhibition.
    Akiu M; Tsuji T; Sogawa Y; Terayama K; Yokoyama M; Tanaka J; Asano D; Sakurai K; Sergienko E; Sessions EH; Gardell SJ; Pinkerton AB; Nakamura T
    Bioorg Med Chem Lett; 2021 Jul; 43():128048. PubMed ID: 33887438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of NAMPT activators to achieve in vivo neuroprotective efficacy.
    Wang L; Liu M; Zu Y; Yao H; Wu C; Zhang R; Ma W; Lu H; Xi S; Liu Y; Hua L; Wang G; Tang Y
    Eur J Med Chem; 2022 Jun; 236():114260. PubMed ID: 35385807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT), an Enzyme Essential for NAD+ Biosynthesis, Leads to Altered Carbohydrate Metabolism in Cancer Cells.
    Tan B; Dong S; Shepard RL; Kays L; Roth KD; Geeganage S; Kuo MS; Zhao G
    J Biol Chem; 2015 Jun; 290(25):15812-15824. PubMed ID: 25944913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of potent NAMPT-Targeting PROTACs using FK866 as the warhead.
    Zhang P; Wang W; Guo M; Zhou L; Dong G; Xu D; Sheng C
    Bioorg Med Chem Lett; 2023 Aug; 92():129393. PubMed ID: 37369332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular Nicotinamide Phosphoribosyltransferase Is a Component of the Senescence-Associated Secretory Phenotype.
    Kuehnemann C; Hu KQ; Butera K; Patel SK; Bons J; Schilling B; Aguayo-Mazzucato C; Wiley CD
    Front Endocrinol (Lausanne); 2022; 13():935106. PubMed ID: 35909566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of Dual Function Agents That Exhibit Anticancer Activity via Catastrophic Nicotinamide Adenine Dinucleotide Depletion.
    Fu Y; Huang Y; Zhou C; Li X; Dong G; Huang M; Ding J; Sheng C
    J Med Chem; 2023 Dec; 66(24):16694-16703. PubMed ID: 38060985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug discovery targeting nicotinamide phosphoribosyltransferase (NAMPT): Updated progress and perspectives.
    Wen F; Gui G; Wang X; Ye L; Qin A; Zhou C; Zha X
    Bioorg Med Chem; 2024 Feb; 99():117595. PubMed ID: 38244254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotinamide phosphoribosyltransferase promotes epithelial-to-mesenchymal transition as a soluble factor independent of its enzymatic activity.
    Soncini D; Caffa I; Zoppoli G; Cea M; Cagnetta A; Passalacqua M; Mastracci L; Boero S; Montecucco F; Sociali G; Lasigliè D; Damonte P; Grozio A; Mannino E; Poggi A; D'Agostino VG; Monacelli F; Provenzani A; Odetti P; Ballestrero A; Bruzzone S; Nencioni A
    J Biol Chem; 2014 Dec; 289(49):34189-204. PubMed ID: 25331943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.